-
Effectiveness of Mesenchymal Stem Cell-Derived Extracellular Vesicles Therapy for Parkinson's Disease: A Systematic Review of Preclinical Studies
26 Apr 2025 19:18 GMT
BACKGROUND
Newswise — Mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) can traverse the blood-brain barrier due to their small size. This characteristic makes them a research hotspot for the treatment of Parkinson’s disease (PD) and is …
-
CK Life Sciences' Investigational Cancer Vaccines Deliver Promising Results - New Preclinical Study Data to be Presented at the 2025 American Association for Cancer Research (AACR) Annual Meeting
22 Apr 2025 11:27 GMT
… exhibit posters highlighting data from preclinical studies of investigational cancer vaccines programs …
-
CG Oncology Announces Best-in-Disease Durability Data in BOND-003 Cohort C and Promising Early Signal in Cohort P for Cretostimogene Grenadenorepvec at the American Urological Association Annual Meeting
26 Apr 2025 20:10 GMT
… from earlier clinical trials and preclinical studies not necessarily being predictive of …
-
Enhancing the Clinical Translation of Stem Cell Models by Focusing on Standardization and International Regulatory Cooperation
26 Apr 2025 19:18 GMT
… stem cell models to refine preclinical studies and align with regulatory requirements … therapy medicinal products; Tissue engineering; Preclinical studies; Clinical translation
Core Tip: Granjeiro …
-
Valneva Provides Update on Recommendation for Use of Its Chikungunya Vaccine by French Authorities
26 Apr 2025 17:10 GMT
… intellectual property protection. Success in preclinical studies or earlier clinical trials may …
-
New drugs target 'zombie cells' to relieve back pain
26 Apr 2025 14:15 GMT
… McGill University.
In a recent preclinical study, the experts explored a radically …
-
Debiopharm, Oncodesign Services announce license agreement for use of AbYlink technology for pre-clinical services
26 Apr 2025 11:34 GMT
… chelator conjugates for use in preclinical studies to gain insights into the …
-
GenVivo Highlights GEN-1013: A Novel Delivery of an IL-12 Immunotherapy at the 2025 American Association for Cancer Research (AACR) Annual Meeting
26 Apr 2025 11:00 GMT
… past IL-12 therapies. In preclinical studies using an aggressive CT26 murine …
-
Nanoparticle-Based Strategies to Enhance the Efficacy of STING Activators in Cancer Immunotherapy
26 Apr 2025 05:08 GMT
… “cold” tumors into “hot” ones. Preclinical studies demonstrate that triple-combination strategies …
-
Annexin A: Cell Death, Inflammation, and Translational Medicine
26 Apr 2025 05:08 GMT
… studies remains a significant challenge. Preclinical studies using diverse animal models have …